Merck KGaA says high asset prices call for prudent M&A approach
The CEO of Germany's Merck KGaA said a recovery in sales growth at its existing business means it can take a cautious approach when it comes to buying other companies, which are expensively priced.
Business Insider27d
Merck’s sotatercept approved by MHRA to treat PAH
The new marketing authorization was granted on December 27 to Merck (MRK) Sharp & Dohme Limited. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news.
Reuters27d
Merck wins UK approval for lung disease drug acquired in $11 billion deal
Dec 31 (Reuters) - UK's Medicines and Healthcare products Regulatory Agency said on Tuesday it had approved Merck's (MRK.N), opens new tab therapy to treat a rare lung condition, marking another ...
Business Insider29d
Bernstein Remains a Hold on Merck & Company (MRK)
Bernstein analyst Courtney Breen maintained a Hold rating on Merck & Company (MRK – Research Report) yesterday and set a price target of $110.00. The company’s shares closed last Friday at $99.70.